DailyStocks Stock Article Search

https://www.rttnews.com/story.aspx?Id=3431229 Mar 11, 2024 - Following the notable downturn seen over the course of last Friday's session, stocks are likely to see further downside in early trading on Monday. The major index futures are currently pointing to a lower open for the markets. Uncertainty about the outlook for interest rates may weigh on the markets ahead of the release of key inflation data in the coming days. 0

https://www.rttnews.com/story.aspx?Id=3431270 Mar 11, 2024 - Stocks have moved mostly lower during trading on Monday, extending the notable downturn seen over the course of last Friday's session. The major averages have all moved to the downside, with the Nasdaq and S&P 500 pulling back further off last week's record highs. Currently, the major averages are off their lows of the session but still in the red. 0

https://www.zacks.com/stock/news/2239578/s-p-500-notches-new-all-time-closing-high?cid=CS-ZC-FT-ahead_of_wall_street-2239578 Mar 12, 2024 - Nearing 3-year lows on core CPI year over year helped the S&P catch a bid today. 0

https://www.rttnews.com/story.aspx?Id=3431999 Mar 13, 2024 - Following the significant rebound seen during Tuesday's session, stocks turned in a relatively lackluster performance during trading on Wednesday. The major averages spent most of the day on opposite sides of the unchanged line before closing mixed. Overall trading activity remained subdued, as a lack of major U.S. economic kept some traders on the sidelines. 0

https://www.zacks.com/stock/news/2240618/are-investors-undervaluing-d-s-smith-dithf-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2240618 Mar 14, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.cnbc.com/2024/03/14/fda-approves-nash-liver-disease-drug-from-madrigal-pharmaceuticals.html Mar 14, 2024 - The FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are still trying to break into. 0

https://www.cnbc.com/2024/03/16/wegovy-heart-health-insurance-coverage.html Mar 16, 2024 - Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets. 0

https://www.fool.com/investing/2024/03/16/this-artificial-intelligence-ai-company-has-return/?source=iedfolrf0000001 Mar 16, 2024 - The "Magnificent Seven" stocks are helping power the markets to new highs. But this other AI company is playing an important role behind the scenes. 0

https://www.cnbc.com/2024/03/18/wegovy-heart-health-insurance-coverage.html Mar 18, 2024 - Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say could significantly strain their budgets. 0

https://seekingalpha.com/article/4678854-why-11-percent-yielding-bizds-run-of-beating-the-s-and-p-500-is-likely-over?source=feed_tag_etf_portfolio_strategy Mar 18, 2024 - BIZD nearly doubled total return performance of S&P 500 over the past 4 years. See why the fund is highly unlikely to continue outperforming moving forward. 0